Ładuje się......
Response evaluation following neoadjuvant treatment of pancreatic cancer patients
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive human neoplastic entities, with a very poor prognosis characterized by a high mortality rate and short survival. This is due both to its aggressive biological behaviour and the high incidence of locally advanced stages at the time...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Baishideng Publishing Group Co., Limited
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3600566/ https://ncbi.nlm.nih.gov/pubmed/23515366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v5.i2.12 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|